SG Americas Securities’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-15,195
| Closed | -$28K | – | 3073 |
|
|
2023
Q1 | $28K | Buy |
15,195
+1,560
| +11% | +$2.88K | ﹤0.01% | 2843 |
|
|
2022
Q4 | $15K | Buy |
13,635
+140
| +1% | +$154 | ﹤0.01% | 2661 |
|
|
2022
Q3 | $32K | Sell |
13,495
-2,273
| -14% | -$5.39K | ﹤0.01% | 2720 |
|
|
2022
Q2 | $48K | Buy |
+15,768
| New | +$48K | ﹤0.01% | 2962 |
|
|
2021
Q4 | – | Sell |
-23,393
| Closed | -$174K | – | 3480 |
|
|
2021
Q3 | $174K | Buy |
+23,393
| New | +$174K | ﹤0.01% | 3055 |
|
|
2019
Q1 | – | Sell |
-16,213
| Closed | -$55K | – | 3048 |
|
|
2018
Q4 | $55K | Buy |
+16,213
| New | +$55K | ﹤0.01% | 2373 |
|
|
2018
Q1 | – | Sell |
-23,079
| Closed | -$294K | – | 2955 |
|
|
2017
Q4 | $294K | Buy |
+23,079
| New | +$294K | ﹤0.01% | 1851 |
|